Thoracic Oncology Program Conditions and Treatments

Conditions Lung cancer Esophageal cancer Mesothelioma Large cell neuroendocrine carcinoma Malignant pleural mesothelioma Mediastinal diseases, tumors and masses Neuroendocrine lung cancer Non-small cell lung cancer Mediastinal tumors Chest wall tumors Small cell lung cancer Thymoma and thymic cancer Pleural disease Treatments Bronchoscopy Robotic bronchoscopy Endobronchial ultrasound Cone-beam computed tomography Minimally invasive, robotic assisted surgery Radiation Therapy Chemotherapy Targeted Therapy Clinical Research Trials Immunotherapy Lung Cancer Screening Program Conditions and Treatments Genomic Cancerous Tumor Assessment The Inova Schar Cancer Institute participates in a genomic cancerous tumor assessment. A member of your care team will collect samples from tumor tissues which are analyzed under the microscope by a pathologist. We systematically perform genetic testing on tumor samples to identify any changes in genes (mutations) than can be targeted with medication. The Inova Molecular Tumor Board is a multidisciplinary team is composed of a Molecular Pathologist, Geneticist, and Medical Oncologists. The Board meets twice weekly to discuss genetic information obtained from tumor tissues to identify the best possible treatment.